RxBiologics
Cambridge, United Kingdom rxbiologics.com From their website, Nov 2026
Work here? Claim this listing
About
RxBiologics provides antibody discovery and optimization services for biologics drug discovery. It serves clients developing therapeutic antibodies and related formats from early discovery through preclinical phases, based at Babraham Research Campus in Cambridge, UK.
Services
Antibody Discovery using the Galaxy® Platform
Generates fully human antibodies with desired specificity, affinity, epitope and biophysical characteristics using the proprietary Galaxy® library platform.
Rapid production of multi-specific antibodies
Produces multispecific antibody formats, including bispecific antibodies using a common light chain approach.
Protein production
Immune Library Generation
Builds custom antibody libraries from immune repertoires for standard and domain antibodies.
Antibody Humanisation
Performs humanisation and deimmunisation within CDR regions to improve antibody properties.
Antibody reformatting and production
Reformats antibodies into bespoke formats and produces antibody fragments and related constructs.
Protein production
In Silico Modelling
Provides modelling, structure prediction, developability prediction, immunogenicity prediction and antibody optimisation using licensed software tools.
Reagent Generation
Provides licensed mammalian cell line work, custom antibody and antigen production, protein purification and QC, and transient cell expression for screening and profiling.
Protein production
Lead Isolation
Carries out high-throughput biochemical assay formats, flow cytometry cell binding analysis, sequence analysis, NGS, antibody profiling, affinity measurements, epitope binning, polyreactivity, AC-SINS, functional assays and biophysical analysis.
12 more services
- Antibody Profiling
- MOA Studies and In Vivo Testing
- Custom antibody and antigen production
- Protein purification and QC
- Transient cell expression
- High throughput biochemical assay formats
- Flow cytometry cell binding analysis
- Affinity (SPR)
- Epitope binning (BLI)
- Polyreactivity AC-SINS
- Functional assays
- Biophysical analysis
Capabilities
- Assays and studies
- Antibodies
- Flow cytometry
- SPR
- BLI
- ELISA
- NGS
17 more
- Biochemical assays
- Immunogenicity
- Binding
- Inhibition
- Flow cytometry cell binding
- Epitope binning
- Polyreactivity
- AC-SINS
- Functional assays
- Biophysical analysis
- Sequence analysis
- Developability prediction
- Immunogenicity prediction
- ELISA profiling
- Affinity (SPR)
- Epitope binning (BLI)
- Polyreactivity AC-SINS
- Scale and capacity
- More than 20 Galaxy programmes
- Therapeutic areas
- Tumour targeting
Instruments and platforms
- SPR
- BLI
- NGS
- Flow cytometry
- ELISA
Modalities and species
- Modalities
- Antibody
- Bispecific
- ADC
- Recombinant protein
- Species and models
- Human B cells
- Mammalian cell lines
- Immune repertoires
Industries served
- Biotech
- Pharma
Company
- Type
- CRO
- Founded
- 2013
- Quality
- Galaxy® is a globally registered tradema
Locations
- Based in
- Cambridge, United Kingdom
- Sites
- Babraham, UK
Contacts
- Phone
- +44 (0)1223 839557